Aterian Reports Fourth Quarter & Full Year 2022 Results   Achieved Substantial Progress Selling Through High Cost Inventory to Drive Margin Expansion Starting In the First Quarter of 2023 Reaffirms Second Half 2023 Adjusted EBITDA Profitability Target ...

Aterian Reports First Quarter 2022 Results Reports First Quarter 2022 Net Revenue of $41.7 Million First Quarter Cash Balance of $44.3 Million NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the...

ARKO Corp. Set to Join Russell 2000 Index RICHMOND, Va., June 16, 2021 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a growing leader in the U.S. convenience store industry, is set to join the broad-market Russell...

Aterian Announces Addition To The Russell 2000 Index NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) announced today that it is set to join the small-cap Russell 2000 Index and broad-market Russell...

Kinnate Biopharma Inc. Announces Its Addition to the Russell 2000® Index SAN FRANCISCO and SAN DIEGO, March 19, 2021 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small...